PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1

IntroductionImmunotherapy, especially immune checkpoint blockade (ICB), holds promise as a therapeutic strategy in colorectal cancer (CRC) by harnessing the patient’s immune system to target malignant cells. Particularly, the PD-1/PD-L1 axis is widely recognized for its critical role in tumor microe...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lvyun Zhu, Ying Qu, Junru Yang, Tong Shao, Jingyu Kuang, Chuanyang Liu, Yanhua Qi, Ming Li, Yingying Li, Sujuan Zhang, Jingyang Wang, Yu Liu, Jiali Liu, Yanming Hu, Lingyun Zhu, Tao Hou
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-12-01
Edice:	Frontiers in Immunology
Témata:	immune checkpoint blockade colorectal cancer antitumor immunity therapeutic target tumor microenvironment
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1486888/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!